Mersana Therapeutics Inc (MRSN) — Financial Flexibility Index
Mersana Therapeutics Inc (MRSN) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of $-3.19 Million (operating CF $-3.19 Million minus capex $0.00) represents 0% of total liabilities ($122.22 Million). Check MRSN PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mersana Therapeutics Inc Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Mersana Therapeutics Inc across 10 annual periods. See Mersana Therapeutics Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Mersana Therapeutics Inc (2015–2024)
Year-by-year free cash flow to debt coverage for Mersana Therapeutics Inc. For the full company profile including market capitalisation, see Mersana Therapeutics Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.53x | $-82.21 Million | $-82.34 Million | $154.17 Million | ▲ +39.5% |
| 2023 | -0.88x | $-166.71 Million | $-168.88 Million | $189.16 Million | ▼ -352.7% |
| 2022 | -0.19x | $-47.17 Million | $-49.36 Million | $242.28 Million | ▲ +88.2% |
| 2021 | -1.65x | $-139.34 Million | $-139.99 Million | $84.37 Million | ▼ -0.8% |
| 2020 | -1.64x | $-74.22 Million | $-74.70 Million | $45.31 Million | ▲ +28.7% |
| 2019 | -2.30x | $-67.14 Million | $-67.74 Million | $29.22 Million | ▼ -197.4% |
| 2018 | -0.77x | $-53.85 Million | $-55.22 Million | $69.71 Million | ▼ -12.9% |
| 2017 | -0.68x | $-41.54 Million | $-42.68 Million | $60.72 Million | ▼ -436.5% |
| 2016 | 0.20x | $32.67 Million | $31.59 Million | $160.71 Million | ▲ +228.7% |
| 2015 | -0.16x | $-9.02 Million | $-9.64 Million | $57.10 Million | — |